NuPathe (PATH)

Add to Watchlists Create an Alert
3.11 -0.03  -0.96%   NASDAQ May 23, 8:00PM BATS Real time Currency in USD

NuPathe Cash from Financing Quarterly:

27.00M for Dec. 31, 2012
View Full Chart

NuPathe Cash from Financing Quarterly Chart

    NuPathe Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 27.00M
    Sept. 30, 2012 -2.109M
    June 30, 2012 -2.119M
    March 31, 2012 -2.17M
    Dec. 31, 2011 -0.689M
    Sept. 30, 2011 -0.275M
    June 30, 2011 9.676M
    March 31, 2011 -0.108M
       
    Dec. 31, 2010 -0.124M
    Sept. 30, 2010 42.82M
    June 30, 2010 14.44M
    March 31, 2010 -0.2508M
    Dec. 31, 2009 -0.2471M
    Sept. 30, 2009 9.858M
    June 30, 2009 -0.2197M
    March 31, 2009 -0.2364M

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    PATH Cash from Financing Quarterly Benchmarks

    Companies
    Cadence Pharmaceuticals 0.053M
    Cytori Therapeutics 16.53M
    ARCA biopharma 1.39M

    PATH Cash from Financing Quarterly Rankings

    Overall 92nd percentile
    592 of 8009
    Sector 92nd percentile
    54 of 687 in Healthcare
    Industry 92nd percentile
    19 of 248 in Biotechnology

    PATH Cash from Financing Quarterly Range, Past 5 Years

    Minimum -2.170M Mar 2012
    Maximum 42.82M Sep 2010
    Average 5.953M